Galmed Pharmaceuticals Ltd.
GLMDNASDAQHealthcareBiotechnology
Previous close
$4.305
−$0.255 · -5.59%
Aug 21, 4:00 PM ET
GLMD company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
33/100
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
37
Expensive
Momentum
22
Weakening
Sentiment
55
Mixed
Risk resilience
34
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- IL
Market position
Day range
Current $4.305
$4.12$4.54
52-week range
Current $4.305
$3.288$13.20
- Open
- $4.54
- Previous close
- $4.56
- Volume
- 21.42K
- Market cap
- 4.45M USD
- 50-day average
- $4.5212
- -4.78% below average
- 200-day average
- $5.6158
- -23.34% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- -751.51K USD
- P/E (TTM)
- -0.27×
- P/B (TTM)
- 0.25×
- P/S (TTM)
- 0×
- EV / EBITDA
- 0.07×
- Earnings yield
- -318.82%
- Free cash flow yield
- -195.30%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 0.00%
- Operating margin
- 0.00%
- Net margin
- 0.00%
- Return on equity
- -65.32%
- Return on assets
- -55.34%
- Return on invested capital
- -53.92%
Financial health
- Debt / equity
- 0×
- Current ratio
- 6.55×
Financial statements
Income trends
Operating income
−8.51M USD-35.55%
Net income
−10.31M USD-37.14%
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development | 4.87M USD | 2.98M USD | 3.57M USD | 13M USD | 27.22M USD |
| Selling, general, and administrative | 3.64M USD | 3.3M USD | 3.92M USD | 4.66M USD | 5.66M USD |
| Operating expenses | 8.51M USD | 6.28M USD | 7.49M USD | 17.65M USD | 32.88M USD |
| Interest income | 914K USD | 503K USD | 375K USD | 297K USD | 562K USD |
| Interest expense | — | 15K USD | 11K USD | 215K USD | 43K USD |
| Depreciation and amortization | — | 83K USD | 31K USD | 35K USD | 42K USD |
| Operating income | −8.51M USD | −6.28M USD | −7.49M USD | −17.65M USD | −32.88M USD |
| Net income | −10.31M USD | −7.52M USD | −6.91M USD | −17.87M USD | −32.47M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 67%
- 4 beats, 2 misses, 0 met estimates
- Average EPS surprise
- -44.88%
- 6 comparable reports
- Latest EPS result
- -2.32
- Estimate -3.04 · Beat by 23.68%
EPS: actual versus estimate
Recent quarterly results
ActualEstimate
Revenue: actual versus estimate
Recent quarterly results
ActualEstimate
GLMD peers
Continue in GoAI
Research GLMDresearch.disclaimer